- Investing Ideas
- Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
3
0 new
Companies which are more than 50% undervalued based on analyst price target.
3 companies
Ryvu Therapeutics
Market Cap: zł318.1m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł13.96
7D
-0.3%
1Y
-56.1%
Molecure
Market Cap: zł113.3m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł5.49
7D
0.5%
1Y
-8.2%
Poltreg
Market Cap: zł110.6m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł18.60
7D
-0.8%
1Y
-42.4%